PLACENTAL ALTERATIONS IN SEVERE PREECLAMPSIA AND THEIR MATERNAL AND NEONATAL IMPACTS: INTEGRATIVE LITERATURE REVIEW
DOI:
https://doi.org/10.36557/2009-3578.2025v11n2p3495-3509Palavras-chave:
preeclampsia; placenta; angiogenic biomarkers; maternal outcomes; neonatal outcomes.Resumo
Severe preeclampsia remains one of the greatest challenges in obstetrics, with significant impacts on maternal and neonatal morbidity and mortality. This study conducted an Integrative Literature Review with the aim of systematizing evidence on placental alterations associated with the disease and their clinical repercussions. The methodological strategy followed validated steps of Evidence-Based Practice, guided by a structured PICo question (pregnant women with severe preeclampsia; identification of placental alterations; context of maternal and neonatal outcomes). Searches were performed in PubMed, Web of Science, ScienceDirect, and SciELO using DeCS/MeSH descriptors, and included original studies in Portuguese and English. Data were organized into a synthesis matrix, and levels of evidence were classified according to the Joanna Briggs Institute; the selection process was described in accordance with PRISMA. Findings converge toward a pattern of placental impairment characterized by villous infarction, fibrinoid deposition, villous hypoplasia, oxidative stress, and failure in spiral artery remodeling, resulting in uteroplacental hypoperfusion. Clinically, these changes were associated with HELLP syndrome, worsening hypertension, and placental abruption. In neonates, intrauterine growth restriction, prematurity, and perinatal death predominated. Angiogenic biomarkers, particularly PlGF and sFlt-1, have emerged as promising tools for early detection and severity stratification, although they still lack broad multicenter standardization and validation. Recurrent limitations among the studies include methodological heterogeneity, small sample sizes, and the absence of standardized protocols for placental evaluation. It is concluded that the placenta plays a central role in the pathophysiology of severe preeclampsia and in determining clinical outcomes. The adoption of combined biomarker panels, alongside standardized placental analysis protocols and multicenter studies with representative samples, may improve diagnosis, guide early management, and reduce maternal and neonatal morbidity and mortality.
Downloads
Referências
BENNY, P. A. et al. A review of omics approaches to study preeclampsia. Placenta, v. 92, p. 17-27, 2020. DOI: https://doi.org/10.1016/j.placenta.2020.01.008. Available from: https://pubmed.ncbi.nlm.nih.gov/32056783/. Accessed on: Aug. 23, 2025.
BENTON, S. J. et al. The clinical heterogeneity of preeclampsia is related to both placental gene expression and placental histopathology. American Journal of Obstetrics and Gynecology, v. 219, n. 6, p. 604.e1-604.e25, Dec. 2018. DOI: https://doi.org/10.1016/j.ajog.2018.09.036. Available from: https://pubmed.ncbi.nlm.nih.gov/30278173/. Accessed on: Aug. 23, 2025.
BISSON, C. et al. Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum. Frontiers in Medicine, v. 10, 2023. DOI: https://doi.org/10.3389/fmed.2023.1144170. Available from: https://www.frontiersin.org/articles/10.3389/fmed.2023.1144170/full. Accessed on: Aug. 20, 2025.
DIMITRIADIS, E. et al. Pre-eclampsia. Nature Reviews Disease Primers, v. 9, Art. no. 8, 2023. DOI: 10.1038/s41572-023-00417-6. Accessed on: Aug. 20, 2025.
DONTHI, D. et al. An objective histopathological scoring system for placental pathology in pre-eclampsia and eclampsia. Cureus, v. 12, n. 10, e11104, Oct. 23, 2020. DOI: https://doi.org/10.7759/cureus.11104. Available from: https://pubmed.ncbi.nlm.nih.gov/33240700/. Accessed on: Aug. 21, 2025.
GANONG, L. H. Integrative reviews of nursing research. Research in Nursing & Health, v. 10, n. 1, p. 1-10, 1987. Available from: https://pubmed.ncbi.nlm.nih.gov/3644366/. Accessed on: Aug. 21, 2025.
GATHIRAM, P.; MOODLEY, J. Pre-eclampsia: its pathogenesis and pathophysiology. Cardiovascular Journal of Africa, v. 27, n. 2, p. 71-78, Mar./Apr. 2016. DOI: https://doi.org/10.5830/CVJA-2016-009. Available from: https://pubmed.ncbi.nlm.nih.gov/27213853/. Accessed on: Aug. 20, 2025.
LEMES, M. A. et al. Evaluation strategies in active learning in higher education in health: integrative review. Revista Brasileira de Enfermagem, v. 47, n. 2, 2021. Available from: https://www.scielo.br/j/reben/a/KG8VgQhpKf9ySfCwjkyNY6w/?lang=en. Accessed on: Aug. 21, 2025.
LOCKWOOD, C.; MUNN, Z.; PORRITT, K. Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation. International Journal of Evidence-Based Healthcare, v. 13, n. 3, p. 179-187, 2015. Available from: https://pubmed.ncbi.nlm.nih.gov/26262565/. Accessed on: Aug. 22, 2025.
LOCKWOOD, C. et al. Systematic reviews of qualitative evidence. In: AROMATARIS, E.; MUNN, Z. (eds.). JBI Manual for Evidence Synthesis. JBI, 2020. Available from: https://jbi-global-wiki.refined.site/space/MANUAL/355860482. Accessed on: Aug. 22, 2025.
MOHER, D. et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Medicine, v. 6, n. 7, e1000097, 2009. DOI: https://doi.org/10.1371/journal.pmed.1000097. Available from: https://pubmed.ncbi.nlm.nih.gov/19621072/. Accessed on: Aug. 22, 2025.
PIETRO, L. et al. Placental findings in preterm and term preeclampsia: an integrative review of the literature. Revista Brasileira de Ginecologia e Obstetrícia, v. 43, n. 7, p. 560-569, Jul. 2021. DOI: https://doi.org/10.1055/s-0041-1730292. Available from: https://pubmed.ncbi.nlm.nih.gov/34461666/. Accessed on: Aug. 22, 2025.
ROBERTS, D. et al. Incorporating placental pathology into clinical care and research. Trends in Molecular Medicine, v. 30, n. 12, p. 1103-1112, Dec. 2024. DOI: https://doi.org/10.1016/j.molmed.2024.08.002. Accessed on: Aug. 24, 2025.
SJAARDA, L. A. et al. Pilot study of placental tissue collection, processing, and measurement procedures for large scale assessment of placental inflammation. PLoS ONE, v. 13, n. 5, e0197039, May 11, 2018. DOI: https://doi.org/10.1371/journal.pone.0197039. Accessed on: Aug. 24, 2025.
SOUZA, M. T.; SILVA, M. D.; CARVALHO, R. Integrative review: what is it? How to do it? Einstein (São Paulo), v. 8, n. 1, p. 102-106, 2010. Available from: https://www.scielo.br/j/eins/a/ZQTBkVJZqcWrTT34cXLjtBx/?lang=pt. Accessed on: Aug. 21, 2025.
STAFF, A. C. et al. Failure of physiological transformation and spiral artery atherosis: their roles in pre-eclampsia. American Journal of Obstetrics and Gynecology, v. 226, suppl. S, p. S895–S906, 2022. DOI: https://doi.org/10.1016/j.ajog.2022.XX. Available from: https://www.sciencedirect.com/science/article/pii/S0002937820311169. Accessed on: Aug. 22, 2025.
STERN, C.; JORDAN, Z.; MCARTHUR, A. Developing the review question and inclusion criteria. The American Journal of Nursing, v. 14, n. 4, p. 53-56, 2014. Available from: https://pubmed.ncbi.nlm.nih.gov/24681476/. Accessed on: Aug. 21, 2025.
STARODUBTSEVA, N. et al. Proteome-based maternal plasma and serum biomarkers for preeclampsia: a systematic review and meta-analysis. Life (Basel), v. 15, n. 5, p. 776, May 13, 2025. DOI: https://doi.org/10.3390/life15050776. Available from: https://pubmed.ncbi.nlm.nih.gov/40430203/. Accessed on: Aug. 23, 2025.
THAN, N. G. et al. Early pathways, biomarkers, and four distinct molecular subclasses of preeclampsia: the intersection of clinical, pathological, and high-dimensional biology studies. Placenta, v. 125, p. 10-19, Jul. 2022. DOI: https://doi.org/10.1016/j.placenta.2022.03.009. Accessed on: Aug. 23, 2025.
VEISANI, Y. et al. Angiogenic factors and the risk of preeclampsia: a systematic review and meta-analysis. International Journal of Reproductive Biomedicine, v. 17, n. 1, p. 1–10, Mar. 3, 2019. DOI: https://doi.org/10.18502/ijrm.v17i1.3815. Available from: https://pubmed.ncbi.nlm.nih.gov/31435580/. Accessed on: Aug. 23, 2025.
VORNIC, I. et al. Oxidative stress and placental pathogenesis: a contemporary overview of potential biomarkers and emerging therapeutics. International Journal of Molecular Sciences, v. 25, n. 22, 12195, Nov. 13, 2024. DOI: https://doi.org/10.3390/ijms252212195. Available from: https://pubmed.ncbi.nlm.nih.gov/39596261/. Accessed on: Aug. 21, 2025.
WORLD HEALTH ORGANIZATION. Pre-eclampsia. Geneva: World Health Organization, Apr. 4, 2025. Available from: https://www.who.int/news-room/fact-sheets/detail/pre-eclampsia. Accessed on: Aug. 20, 2025.
ZEGARRA, R. R.; GHI, T.; LEES, C. Does the use of angiogenic biomarkers for the management of preeclampsia and fetal growth restriction improve outcomes?: challenging the current status quo. European Journal of Obstetrics & Gynecology and Reproductive Biology, v. 300, p. 268-277, Sep. 2024. DOI: https://doi.org/10.1016/j.ejogrb.2024.07.042. Available from: https://www.sciencedirect.com/science/article/pii/S030121152400397X. Accessed on: Aug. 23, 2025.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2025 Lívia de Oliveira Alves, Letícia de Oliveira Alves, Rodolfo de Oliveira Medeiros, Cristiano Machado Galhardi, Letícia Francisco de Azevedo, Priscila Alvin de Lima Ravagnani, Ana Lara Gomes dos Santos, Melyssa Xavier Ferreira, Pamella Xavier Ferreira, Mariana Gomes Agulhon, Júlia Maria Machado Luiz, Isabela da Silva Ventura, Livia Colombo Carrero, Cynthia de Paula Costa Borba, Paula Takano Golono
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Você tem o direito de:
- Compartilhar — copiar e redistribuir o material em qualquer suporte ou formato para qualquer fim, mesmo que comercial.
- Adaptar — remixar, transformar, e criar a partir do material para qualquer fim, mesmo que comercial.
De acordo com os termos seguintes:
- Atribuição — Você deve dar o crédito apropriado , prover um link para a licença e indicar se mudanças foram feitas . Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso.
- Sem restrições adicionais — Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.
